Evaluation of XTR004 as a Novel 18F-labeled PET MPI Tracer in Diagnosis of Known or Suspected CAD
Clinical trial NCT05885841 · COMPLETED
Trial details
- NCT number
- NCT05885841
- Sponsor
- Sinotau Pharmaceutical Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2023-05-09
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.